Heidegger Mateos‐Toledo

514 total citations
23 papers, 335 citations indexed

About

Heidegger Mateos‐Toledo is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Epidemiology. According to data from OpenAlex, Heidegger Mateos‐Toledo has authored 23 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 9 papers in Rheumatology and 8 papers in Epidemiology. Recurrent topics in Heidegger Mateos‐Toledo's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Inflammatory Myopathies and Dermatomyositis (8 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). Heidegger Mateos‐Toledo is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Inflammatory Myopathies and Dermatomyositis (8 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). Heidegger Mateos‐Toledo collaborates with scholars based in Mexico, Venezuela and United States. Heidegger Mateos‐Toledo's co-authors include Mayra Mejía, Jorge Rojas‐Serrano, Ramcés Falfán‐Valencia, Montserrat I. González-Pérez, Ivette Buendía-Roldán, Gloría Pérez-Rubio, Ivette Buendía-Roldán, Espiridión Ramos-Martı́nez, Moisés Selman and Luis Felipe Flores-Suárez and has published in prestigious journals such as Cells, Respiratory Medicine and Journal of Clinical Medicine.

In The Last Decade

Heidegger Mateos‐Toledo

22 papers receiving 329 citations

Peers

Heidegger Mateos‐Toledo

PRM

EPIDE

PHYSI

RHEUM

PFM

Helena Andersson Norway

Moo‐Seok Park South Korea

Hannu-Pekka Kettunen Finland

D. Malesci Italy

Gorica Ristić Serbia

Shehabaldin Alqalyoobi United States

Karla Pearson United States

Jure Tornic Switzerland

Peter Woolfson United Kingdom

Xiaofeng Zeng China

Helena Andersson Norway

Heidegger Mateos‐Toledo

102 ×0.4

PRM

197 ×1.2

EPIDE

15 ×0.1

PHYSI

79 ×0.7

RHEUM

61 ×0.8

PFM

Citations per year, relative to Heidegger Mateos‐Toledo Heidegger Mateos‐Toledo (= 1×) peers Helena Andersson

Countries citing papers authored by Heidegger Mateos‐Toledo

Since Specialization

Citations

This map shows the geographic impact of Heidegger Mateos‐Toledo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidegger Mateos‐Toledo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidegger Mateos‐Toledo more than expected).

Fields of papers citing papers by Heidegger Mateos‐Toledo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidegger Mateos‐Toledo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidegger Mateos‐Toledo. The network helps show where Heidegger Mateos‐Toledo may publish in the future.

Co-authorship network of co-authors of Heidegger Mateos‐Toledo

This figure shows the co-authorship network connecting the top 25 collaborators of Heidegger Mateos‐Toledo. A scholar is included among the top collaborators of Heidegger Mateos‐Toledo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidegger Mateos‐Toledo. Heidegger Mateos‐Toledo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mejía, Mayra, et al.. (2024). Pulmonary manifestations and prognosis of a cohort of patients with interstitial lung disease and positive to anti-Th/To autoantibodies. Medicina Clínica. 162(8). 378–384.

Mejía, Mayra, Espiridión Ramos-Martı́nez, Heidegger Mateos‐Toledo, et al.. (2024). MUC5B rs35705950 Promoter Variant Is Associated with Usual Interstitial Pneumonia in Patients with Antisynthetase Syndrome. Journal of Clinical Medicine. 13(20). 6159–6159. 1 indexed citations

Cortés-Telles, Arturo, et al.. (2024). Mexican Hispanics show significant improvement in lung function approximately 1 year after having severe COVID‐19. Experimental Physiology. 109(12). 2147–2157. 3 indexed citations

Mejía, Mayra, Héctor Isaac Rocha‐González, Ramcés Falfán‐Valencia, et al.. (2024). Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study. Clinical Rheumatology. 43(6). 1971–1978. 1 indexed citations

Ramos-Martı́nez, Espiridión, Ramcés Falfán‐Valencia, Gloría Pérez-Rubio, et al.. (2023). Clinical risk factors in patients with interstitial lung disease associated with anti-MDA5 autoantibodies. Medicina Clínica. 161(12). 515–522. 1 indexed citations

Ramos-Martı́nez, Espiridión, Gloría Pérez-Rubio, Mayra Mejía, et al.. (2022). Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome. Cells. 12(1). 60–60. 5 indexed citations

Ramos-Martı́nez, Espiridión, Ramcés Falfán‐Valencia, Gloría Pérez-Rubio, et al.. (2022). Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163. Immunology Letters. 248. 56–61. 3 indexed citations

Rojas‐Serrano, Jorge, et al.. (2022). Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis. Clinical Rheumatology. 41(6). 1741–1747. 17 indexed citations

Ramos-Martı́nez, Espiridión, Ramcés Falfán‐Valencia, Gloría Pérez-Rubio, et al.. (2020). Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile. Journal of Clinical Medicine. 9(5). 1356–1356. 21 indexed citations

10.

Mateos‐Toledo, Heidegger, Mayra Mejía, Jorge Rojas‐Serrano, et al.. (2020). An Open-label Study With Pirfenidone on Chronic Hypersensitivity Pneumonitis. Archivos de Bronconeumología. 56(3). 163–169. 6 indexed citations

11.

González-Pérez, Montserrat I., Ivette Buendía-Roldán, Mayra Mejía, et al.. (2019). Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies. The Journal of Rheumatology. 47(3). 415–423. 25 indexed citations

12.

Mateos‐Toledo, Heidegger, Mayra Mejía, Jorge Rojas‐Serrano, et al.. (2019). An Open-label Study With Pirfenidone on Chronic Hypersensitivity Pneumonitis. Archivos de Bronconeumología. 56(3). 163–169. 21 indexed citations

13.

Rojas‐Serrano, Jorge, et al.. (2017). Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Clinical Rheumatology. 36(7). 1493–1500. 89 indexed citations

14.

Flores-Suárez, Luis Felipe, et al.. (2017). Pulmonary Involvement in Systemic Vasculitis. Current Rheumatology Reports. 19(9). 56–56. 8 indexed citations

15.

Mejía, Mayra, et al.. (2016). Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF). Respiratory Medicine. 123. 79–86. 41 indexed citations

16.

Mateos‐Toledo, Heidegger, et al.. (2016). Enfermedad pulmonar intersticial temprana en poliangitis microscópica: reporte de un caso y revisión de la literatura. Reumatología Clínica. 14(2). 106–108. 1 indexed citations

17.

Mejía, Mayra, et al.. (2016). Primer Consenso Mexicano sobre Fibrosis Pulmonar Idiopática. 75(1). 32–51. 1 indexed citations

18.

Valdespino-Vázquez, María Yolotzín, et al.. (2016). Hemorragia alveolar difusa: frecuencia, causa y desenlace. 32(2). 169–175. 1 indexed citations

19.

Rojas‐Serrano, Jorge, et al.. (2015). Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD). Clinical Rheumatology. 34(9). 1563–1569. 49 indexed citations

20.

Mejía, Mayra, et al.. (2014). Rheumatoid arthritis-associated interstitial lung disease: Lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity. Reumatología Clínica. 11(1). 12–16. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact